| Literature DB >> 26112199 |
Ana Barac1, Gillian Murtagh2, Joseph R Carver3, Ming Hui Chen4, Andrew M Freeman5, Joerg Herrmann6, Cezar Iliescu7, Bonnie Ky8, Erica L Mayer9, Tochi M Okwuosa10, Juan Carlos Plana11, Thomas D Ryan12, Anne K Rzeszut13, Pamela S Douglas14.
Abstract
Many existing and emerging cancer therapies have a significant effect on the cardiovascular health of patients with cancer and cancer survivors. This paper examines current aspects of interdisciplinary cardio-oncology clinical care delivery and education in the United States and outlines how these data provide a platform for future development of the field. We present the results of the nationwide survey on cardio-oncology services, practices, and opinions, conducted among chiefs of cardiology and program directors, which demonstrate ranges of clinical activities and identify significant interest for increased educational opportunities and expert training of cardiovascular physicians in this field. The survey respondents recognized clinical relevance but emphasized lack of national guidelines, lack of funds, and limited awareness and infrastructure as the main challenges for development and growth of cardio-oncology. We discuss potential solutions to unmet needs through interdisciplinary collaboration and the active roles of professional societies and other stakeholders.Entities:
Keywords: cancer survivorship; cardio-oncology; cardiovascular risk prevention; cardiovascular toxicity
Mesh:
Year: 2015 PMID: 26112199 PMCID: PMC4484773 DOI: 10.1016/j.jacc.2015.04.059
Source DB: PubMed Journal: J Am Coll Cardiol ISSN: 0735-1097 Impact factor: 24.094